SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-238117
Filing Date
2024-10-16
Accepted
2024-10-16 16:06:00
Documents
13
Period of Report
2024-10-11
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d773987d8k.htm   iXBRL 8-K 24280
  Complete submission text file 0001193125-24-238117.txt   146296

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA grts-20241011.xsd EX-101.SCH 2855
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE grts-20241011_lab.xml EX-101.LAB 17996
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grts-20241011_pre.xml EX-101.PRE 11265
15 EXTRACTED XBRL INSTANCE DOCUMENT d773987d8k_htm.xml XML 3634
Mailing Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608
Business Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608 (510) 871-6100
Gritstone bio, Inc. (Filer) CIK: 0001656634 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38663 | Film No.: 241374636
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)